The Level of HBV DNA at Month 12 Is an Important Predictor of Virological Breakthrough During Adefovir Monotherapy in Chronic Hepatitis B Patients with Lamivudine Resistance

Author： Kim Moon-Chan   Jung Seok   Shin Jung   Park Neung  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.4, 2011-04, pp. : 1215-1221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B

By  

Digestion, Vol. 87, Iss. 3, 2013-05 ,pp. : 196-203

Karger

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 3, 2006-03 ,pp. : 283-285

Springer Publishing Company

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 927-927

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection

By Tanaka Yasuhito   Yeo Anthony E.T.   Orito Etsuro   Ito Kiyoaki   Hirashima Noboru   Ide Tatsuya   Sata Michio   Mizokami Masashi  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 769-775

Springer Publishing Company

Access to resources Recommend Favorite

Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B

By Wu Shuang   Fukai Kenichi   Imazeki Fumio   Arai Makoto   Kanda Tatsuo   Yonemitsu Yutaka   Yokosuka Osamu  

Digestive Diseases and Sciences, Vol. 56, Iss. 4, 2011-04 ,pp. : 1207-1214

Springer Publishing Company

Access to resources Recommend Favorite